Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

Rambam Health Care Campus600 enrolled

Overview

Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.

Study Type

OBSERVATIONAL

Enrollment

600

Conditions

Basal Cell Carcinoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: All patients that underwent an incomplete BCC excision during the years 2008-2010. Exclusion Criteria: Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.